PanTera
PrivateLast Round
Series A
Sep 11, 2024
Est. Valuation
$308.3M
Total Funding Raised
$110.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PanTera is a life sciences company that produces actinium-225, a radioisotope used in next-generation radiopharmaceuticals for targeted cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PanTera Comparables
Compare PanTera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlfaRim Medical | 85% | |
| Niowave Inc. | 79% | |
| Nusano | 78% |
PanTera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 11, 2024 | ||||
| Debt | Sep 11, 2024 | ||||
| Convertible Debt | Sep 22, 2022 |
PanTera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Convertible Debt, Series A |
| EQT Life Sciences | Series A |
| Korys | Series A |
| Paladin Capital Group | Series A |
| KBC Group N.V. | Debt |
| PMV | Series A |
| Eurazeo | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Grew 15% QoQ, from 59 to 68 employees.
- Dec 22, 2025
Grew 19% QoQ, from 42 to 50 employees.
PanTera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PanTera's valuation, stock price, and market status.
Is PanTera a public or private company?
PanTera is a private company.
What is the current stock price of PanTera?
PanTera is a private company with no public stock price. No recent secondary market data is available.
How much is PanTera worth (valuation)?
PanTera's valuation is estimated at $308.3M based on funding round data.
Can I buy PanTera stock?
PanTera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PanTera's last funding round?
PanTera's most recent funding round was Series A on September 11, 2024.
Who are the main investors in PanTera?
Key investors in PanTera include EQT Life Sciences.
Will PanTera IPO soon?
No public IPO plans have been announced for PanTera.
How can I track PanTera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PanTera's secondary market activity and sign up for updates.